Loading stock data…
The Cooper Companies, Inc. (COO)
$70.31+0.08 (+0.11%)
Market ClosedLast close Jul 24
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Cooper Companies, Inc. in the Healthcare sector is trading at $70.31 with a market capitalization of $14.5B. Wall Street consensus targets $81.69 (13 analysts), implying a +16.2% move over the next 12 months. The stock is currently 22% below its 52-week high of $89.83, remaining 3.7% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: MACD remains below its signal line. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +16.2% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.08B↑ | $1.02B↓ | $1.07B↑ | $1.06B↑ | $1.00B |
| Gross Profit | $735.40M↑ | $695.20M↑ | $650.80M↓ | $692.00M↑ | $679.10M |
| Operating Income | -$31.00M↓ | $212.80M↑ | $140.40M↓ | $175.70M↓ | $184.80M |
| Net Income | -$77.90M↓ | $130.80M↑ | $84.60M↓ | $98.30M↑ | $87.70M |
Peer Comparison
JNJUNHPFE
Fundamentals
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifo...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$14.47B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
62.88
Beta
Defensive asset. Lower volatility than the S&P 500.
0.84
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
2.86%
Volume
Today's trading volume
1.40M
Recent News
The Cooper Companies’ Q2 2026 Earnings: What to Expect
The Cooper Companies is set to report Q3 earnings, with analysts expecting a marginal year-over-year EPS growth.
1 Profitable Stock to Research Further and 2 We Turn Down
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now
Cooper Companies' premium contact lenses, restructuring gains and product launches support growth despite regional and competitive headwinds.
2 Momentum Stocks to Consider Right Now and 1 We Turn Down
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding up shares.
How COO Is Balancing Premium Lens Growth Against Asia-Pacific Risks?
COO's premium lens, myopia control and fertility momentum support growth, but Asia-Pacific weakness and margin pressure keep the outlook measured.